UChicago Medicine Faculty Physicians
James J. Curran, MD
James J. Curran, MD
UChicago Medicine Faculty Physicians
Clinical Professor of Medicine
Specialties
- Rheumatology
Locations
- Chicago - Hyde Park
- About
- Specialties & Areas of Expertise
- Locations & Patient Information
- Education & Research
- Accepted Insurance
- External Professional Relationships
James Curran, MD, is an expert rheumatologist, specializing in late onset rheumatoid arthritis. He was the first doctor to define therapeutic requirements and clinical outcomes of the disease, when he published the initial 50 cases in Seminars of Arthritis & Rheumatism in 1992. Dr. Curran also has expertise in inflammatory muscle diseases, including polymyositis and dermatomyositis.
Dr. Curran's research focuses on improving treatment options for patients with inflammatory diseases. In one study, he examined the use of IL6 and Rituxan to treat advanced rheumatoid arthritis. In another, he and his colleagues studied the impact of tumor necrosis factor (TNF) inhibitors in patients with refractory sarcoidosis.
An accomplished author and speaker, Dr. Curran has published abstracts and articles in several peer-reviewed journals and is frequently asked to present at conferences on arthritis and autoimmune disease. For the past 10 years, he has been named one of the "Top Doctors in Chicago" by Chicago magazine and one of "America’s Top Doctors" by Castle Connolly Medical Ltd.
Dr. Curran's research focuses on improving treatment options for patients with inflammatory diseases. In one study, he examined the use of IL6 and Rituxan to treat advanced rheumatoid arthritis. In another, he and his colleagues studied the impact of tumor necrosis factor (TNF) inhibitors in patients with refractory sarcoidosis.
An accomplished author and speaker, Dr. Curran has published abstracts and articles in several peer-reviewed journals and is frequently asked to present at conferences on arthritis and autoimmune disease. For the past 10 years, he has been named one of the "Top Doctors in Chicago" by Chicago magazine and one of "America’s Top Doctors" by Castle Connolly Medical Ltd.
Specialties
Areas of Expertise
- Lupus
- Polymyositis
- Vasculitis
- Rheumatoid Arthritis
- Dermatomyositis
UChicago Medicine Duchossois Center for Advanced Medicine - Hyde Park5758 S. Maryland Ave., Chicago IL 606371-888-824-0200
Board Certifications
- Internal Medicine
- Rheumatology
Practicing Since
- 1976
Languages Spoken
- English
Medical Education
- University of Illinois - Chicago
Internship
- Walter Reed National Military Medical Center
Residency
- National Naval Medical Center
Fellowship
- University of Chicago Medicine
Memberships & Medical Societies
- American College of Physicians
- Chicago Medical Society
- American Rheumatism Association
- Chicago Rheumatism Society
- Scleroderma Foundation of Greater Chicago
- Lupus Foundation of America
- American Medical Association
- Arthritis Foundation
News & Research
Insurance
- Aetna Better Health *see insurance page
- Aetna HMO (specialists only)
- Aetna Medicare Advantage HMO & PPO
- Aetna POS
- Aetna PPO
- BCBS Blue Precision HMO (specialists only)
- BCBS HMO (HMOI) (specialists only)
- BCBS Medicare Advantage HMO & PPO
- BCBS PPO
- Cigna HMO
- Cigna POS
- Cigna PPO
- CountyCare *see insurance page
- Humana Medicare Advantage Choice PPO
- Humana Medicare Advantage Gold Choice PFFS
- Humana Medicare Advantage Gold Plus HMO
- Medicare
- Multiplan PPO
- PHCS PPO
- United Choice Plus POS/PPO
- United Choice HMO (specialists only)
- United Options (PPO)
- United Select (HMO & EPO) (specialists only)
- United W500 Emergent Wrap
- University of Chicago Health Plan (UCHP)
Our list of accepted insurance providers is subject to change at any time. You should contact your insurance company to confirm UChicago Medicine participates in their network before scheduling your appointment. If you have questions regarding your insurance benefits at UChicago Medicine, please contact our financial counseling team at OPSFinancialCounseling@uchospitals.edu.
UChicago Medicine is committed to fostering a corporate culture of ethical behavior and integrity in all matters related to compliance with the laws and regulations that govern the delivery of healthcare. This aspiration is central to supporting patient care, research, and teaching at UChicago Medicine.
Some of our physicians and health professionals collaborate with external pharmaceutical, medical device, or other medical related entities to develop new treatments and products to improve clinical outcomes for patients. In some instances, the physician has ownership interests in the external entity and/or is compensated for advising or speaking about the entity’s products or treatments. These payments may include compensation for consulting and speaking engagements, equity, and/or royalties for products invented by our physicians. To assure objectivity and integrity in patient care, UChicago Medicine requires all physicians and health professionals to report their relationships and financial interests with external entities on an annual basis. This information is used to review relationships and transactions that might give rise to potential financial conflicts of interest, and when considered to be significant a management plan to mitigate any biases is created.
If you are a patient at UChicago Medicine and would like more information about your physician’s external relationships, please talk with your physician. You may also visit the Centers for Medicare & Medicaid Services (CMS) Open Payments website at https://openpaymentsdata.cms.gov/ . CMS Open Payments is a national disclosure program that promotes a more transparent and accountable health care system. It houses a publicly accessible database of payments that reporting entities, including drug and medical device companies, make to covered recipients like physicians and hospitals.
Information in the CMS Open Payments database could potentially contain inaccurately reported and out of date payment information. All information is open to personal interpretation, if there are questions about the data, patients and their advocates should speak directly to their health care provider for a better understanding.
Some of our physicians and health professionals collaborate with external pharmaceutical, medical device, or other medical related entities to develop new treatments and products to improve clinical outcomes for patients. In some instances, the physician has ownership interests in the external entity and/or is compensated for advising or speaking about the entity’s products or treatments. These payments may include compensation for consulting and speaking engagements, equity, and/or royalties for products invented by our physicians. To assure objectivity and integrity in patient care, UChicago Medicine requires all physicians and health professionals to report their relationships and financial interests with external entities on an annual basis. This information is used to review relationships and transactions that might give rise to potential financial conflicts of interest, and when considered to be significant a management plan to mitigate any biases is created.
If you are a patient at UChicago Medicine and would like more information about your physician’s external relationships, please talk with your physician. You may also visit the Centers for Medicare & Medicaid Services (CMS) Open Payments website at https://openpaymentsdata.cms.gov/ . CMS Open Payments is a national disclosure program that promotes a more transparent and accountable health care system. It houses a publicly accessible database of payments that reporting entities, including drug and medical device companies, make to covered recipients like physicians and hospitals.
Information in the CMS Open Payments database could potentially contain inaccurately reported and out of date payment information. All information is open to personal interpretation, if there are questions about the data, patients and their advocates should speak directly to their health care provider for a better understanding.